Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial

Cephalalgia - United States
doi 10.1177/0333102410365106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications


Related search